Results 11 to 20 of about 195,376 (282)

c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases. [PDF]

open access: yesThe Open Rheumatology Journal, 2012
The c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein kinase (MAPK) family and are activated by environmental stress. JNK is also activated by proinflammatory cytokines, such as TNF and IL-1, and Toll-like receptor ligands ...
Firestein, Gary S, Guma, Monica
core   +6 more sources

Investigation of c-Jun N-terminal Kinase 2 Regulation [PDF]

open access: yes, 2017
JNK2). This protein is unique in that it can autophosphorylate, or phosphorylate itself. It was found that these proteins tend to form aggregates of four, or tetramers, when inactive and remain as single units, or monomers, when active.
Go, Jaeeun
core   +3 more sources

c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1. [PDF]

open access: yesCancer Gene Ther, 2022
AbstractThe c-Jun N-terminal protein kinases (JNKs) JNK1 and JNK2 can act as either tumor suppressors or pro-oncogenic kinases in human cancers. The isoform-specific roles for JNK1 and JNK2 in human pancreatic cancer are still unclear, the question which should be addressed in this project.
Tian X   +9 more
europepmc   +5 more sources

Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation

open access: yesCells, 2020
Neuroinflammation is involved in the progression or secondary injury of multiple brain conditions, including stroke and neurodegenerative diseases.
Nina D. Anfinogenova   +3 more
doaj   +1 more source

Activation of c-Jun N-Terminal Kinase, a Potential Therapeutic Target in Autoimmune Arthritis

open access: yesCells, 2020
The c-Jun-N-terminal kinase (JNK) is a critical mediator involved in various physiological processes, such as immune responses, and the pathogenesis of various diseases, including autoimmune disorders.
Benjamin Lai   +2 more
doaj   +1 more source

Research progress on the inflammatory mechanisms of cholestatic liver injury [PDF]

open access: yesJichu yixue yu linchuang, 2022
Cholestatic liver injury (CLI) is a liver disease with high mordity. Accumulation of bile acids in the liver is thought to be a major driver of liver injury during cholestasis.
KANG Jin-yu, LUO Jia, GAO Ze-tian, ZHENG Wen-tao, LIU Ai-ming, SONG Yu-fei
doaj   +1 more source

c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK) [PDF]

open access: yes, 2004
The VRK1 kinase is a novel Ser-Thr kinase in the human kinome that diverged from the casein kinase 1 branch. These kinases phosphorylate transcription factors related to stress responses, such as p53.
Liu, Tingting   +5 more
core   +1 more source

c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis

open access: yesCells, 2020
c-Jun N-terminal kinase (JNK) is upregulated during multiple sclerosis relapses and at the peak of experimental autoimmune encephalomyelitis (EAE).
Maud Bagnoud   +8 more
doaj   +1 more source

TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis. [PDF]

open access: yes, 2014
In addition to regulating the activation of nuclear factor (NF)-κB and c-Jun N-terminal kinase (JNK), TGF-β activated kinase 1 (TAK1) also upregulates the activation of AMP-activated protein kinase (AMPK) and autophagy.
Seki, Ekihiro
core   +2 more sources

FLEXIQinase, a mass spectrometry-based assay, to unveil multi-kinase mechanisms [PDF]

open access: yes, 2012
We introduce a mass spectrometry-based method that provides residue-resolved quantitative information about protein phosphorylation. In this FLEXIQinase assay we combined our Full-Length Expressed Stable Isotope-labeled Protein for Quantification ...
Bilimoria, Parizad Maheyar   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy